Skip to contentM
Medtronic plc
M
MDTMedtronic plc Q3 2024 · 10-Q
Revenue$8.09B$8.09B+4.7% vs Q3 2023 Net Income$1.32B$1.32B+8.2% vs Q3 2023 EPS Diluted$0.99$0.99+7.6% vs Q3 2023 Operating Income$1,483,000,000+6.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medtronic plc · CIK 1613103 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,128,000,000+71.3% Margins · derivedOperating margin18.3%+0.3 pt vs Q3 2023
Net margin16.3%+0.5 pt vs Q3 2023
ended Jan 26, 2024 · filed Feb 27, 2024 · 32 d after period end